Vaxart, Inc. Pre-Tax Income
Vaxart, Inc. (VXRT) reported Pre-Tax Income of -$13.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-06
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$13.46M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was $5.21M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was $55.39M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$8.12M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$82.20M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$107.69M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$70.36M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$31.98M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.46M 10-Q · filed 2026-08-06 | -$8.26M 10-Q · filed 2026-08-06 | $47.13M derived: sum of 3 quarters · filed 2026-08-06 | $39.01M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $5.21M S-1 · filed 2026-05-08 | $60.60M derived: sum of 2 quarters · filed 2026-05-08 | $52.47M derived: sum of 3 quarters · filed 2026-05-08 | $37.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $55.39M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $47.27M derived: sum of 2 quarters · filed 2026-05-08 | $32.30M derived: sum of 3 quarters · filed 2026-08-06 | $16.80M S-1 · filed 2026-05-08 | ||||
| 2025-09-30 | -$8.12M 10-Q · filed 2025-11-13 | -$23.09M derived: sum of 2 quarters · filed 2026-08-06 | -$38.59M 10-Q · filed 2025-11-13 | -$50.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$14.97M 10-Q · filed 2026-08-06 | -$30.46M 10-Q · filed 2026-08-06 | -$42.27M derived: sum of 3 quarters · filed 2026-08-06 | -$56.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$15.50M S-1 · filed 2026-05-08 | -$27.30M derived: sum of 2 quarters · filed 2026-05-08 | -$41.37M derived: sum of 3 quarters · filed 2026-05-08 | -$57.81M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$11.81M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | -$25.87M derived: sum of 2 quarters · filed 2026-05-08 | -$42.32M derived: sum of 3 quarters · filed 2026-05-08 | -$66.69M S-1 · filed 2026-05-08 | ||||
| 2024-09-30 | -$14.06M 10-Q · filed 2025-11-13 | -$30.51M derived: sum of 2 quarters · filed 2025-11-13 | -$54.88M 10-Q · filed 2025-11-13 | -$72.08M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$16.45M 10-Q · filed 2025-08-13 | -$40.82M 10-Q · filed 2025-08-13 | -$58.02M derived: sum of 3 quarters · filed 2025-08-13 | -$75.38M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$24.37M 10-Q · filed 2025-05-13 | -$41.57M derived: sum of 2 quarters · filed 2025-05-13 | -$58.93M derived: sum of 3 quarters · filed 2025-05-13 | -$81.47M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$17.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$34.56M derived: sum of 2 quarters · filed 2025-03-20 | -$57.09M derived: sum of 3 quarters · filed 2025-03-20 | -$82.20M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$17.36M 10-Q · filed 2024-11-13 | -$39.89M derived: sum of 2 quarters · filed 2024-11-13 | -$65.00M 10-Q · filed 2024-11-13 | -$88.91M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$22.53M 10-Q · filed 2024-08-08 | -$47.64M 10-Q · filed 2024-08-08 | -$71.54M derived: sum of 3 quarters · filed 2024-08-08 | -$100.84M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$25.11M 10-Q · filed 2024-05-13 | -$49.01M derived: sum of 2 quarters · filed 2024-05-13 | -$78.31M derived: sum of 3 quarters · filed 2024-05-13 | -$107.72M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$53.20M derived: sum of 2 quarters · filed 2024-03-14 | -$82.61M derived: sum of 3 quarters · filed 2024-03-14 | -$107.69M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$29.29M 10-Q · filed 2023-11-02 | -$58.71M derived: sum of 2 quarters · filed 2023-11-02 | -$83.79M 10-Q · filed 2023-11-02 | -$104.53M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$29.41M 10-Q · filed 2023-08-03 | -$54.50M 10-Q · filed 2023-08-03 | -$75.24M derived: sum of 3 quarters · filed 2023-08-03 | -$92.80M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$25.08M 10-Q · filed 2023-05-04 | -$45.83M derived: sum of 2 quarters · filed 2023-05-04 | -$63.39M derived: sum of 3 quarters · filed 2023-05-04 | -$79.47M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$20.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$38.31M derived: sum of 2 quarters · filed 2023-03-15 | -$54.39M derived: sum of 3 quarters · filed 2023-03-15 | -$70.36M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$17.56M 10-Q · filed 2022-11-09 | -$33.65M derived: sum of 2 quarters · filed 2022-11-09 | -$49.62M 10-Q · filed 2022-11-09 | -$63.45M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$16.09M 10-Q · filed 2022-08-08 | -$32.05M 10-Q · filed 2022-08-08 | -$45.88M derived: sum of 3 quarters · filed 2022-08-08 | -$53.94M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$15.97M 10-Q · filed 2022-05-09 | -$29.80M derived: sum of 2 quarters · filed 2022-05-09 | -$37.86M derived: sum of 3 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | -$13.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$21.89M derived: sum of 2 quarters · filed 2022-02-24 | -$31.98M 10-K · filed 2022-02-24 | |||||
| 2020-09-30 | -$8.06M 10-Q · filed 2021-11-04 | -$18.15M 10-Q · filed 2021-11-04 | ||||||
| 2019-12-31 | -$18.16M 10-K · filed 2022-02-24 | |||||||
| 2017-12-31 | -$3.30M 10-Q · filed 2018-02-06 | -$8.60M 10-Q · filed 2018-02-06 | -$14.50M derived: sum of 3 quarters · filed 2018-02-06 | -$18.70M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2017-09-30 | -$5.30M 10-Q · filed 2017-11-07 | -$11.20M derived: sum of 2 quarters · filed 2017-11-07 | -$15.40M derived: sum of 3 quarters · filed 2017-11-07 | -$24.40M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2017-06-30 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | -$10.10M derived: sum of 2 quarters · filed 2017-09-01 | -$19.10M derived: sum of 3 quarters · filed 2018-02-06 | -$29.10M 10-K · filed 2017-09-01 | ||||
| 2017-03-31 | -$4.20M 10-Q · filed 2017-05-08 | -$13.20M derived: sum of 2 quarters · filed 2018-02-06 | -$23.20M 10-Q · filed 2017-05-08 | -$30.20M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2016-12-31 | -$9.00M 10-Q · filed 2018-02-06 | -$19.00M 10-Q · filed 2018-02-06 | -$26.00M derived: sum of 3 quarters · filed 2018-02-06 | -$31.20M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2016-09-30 | -$10.00M 10-Q · filed 2017-11-07 | -$17.00M derived: sum of 2 quarters · filed 2017-11-07 | -$22.20M derived: sum of 3 quarters · filed 2017-11-07 | -$28.70M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | -$12.20M derived: sum of 2 quarters · filed 2017-09-01 | -$18.70M derived: sum of 3 quarters · filed 2017-09-01 | -$25.40M 10-K · filed 2017-09-01 | ||||
| 2016-03-31 | -$5.20M 10-Q · filed 2017-05-08 | -$11.70M derived: sum of 2 quarters · filed 2017-05-08 | -$18.40M 10-Q · filed 2017-05-08 | -$38.30M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | -$6.50M 10-Q · filed 2017-02-06 | -$13.20M 10-Q · filed 2017-02-06 | -$33.10M derived: sum of 3 quarters · filed 2017-02-06 | -$31.90M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-09-30 | -$6.60M 10-Q · filed 2015-11-06 | -$26.60M derived: sum of 2 quarters · filed 2016-09-13 | -$25.40M derived: sum of 3 quarters · filed 2016-09-13 | -$18.90M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2015-06-30 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$18.80M derived: sum of 2 quarters · filed 2016-09-13 | -$12.30M derived: sum of 3 quarters · filed 2016-09-13 | -$19.20M 10-K · filed 2016-09-13 | ||||
| 2015-03-31 | $1.20M 10-Q · filed 2016-05-10 | $7.70M derived: sum of 2 quarters · filed 2016-05-10 | $800.00K 10-Q · filed 2016-05-10 | -$9.60M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-12-31 | $6.50M 10-Q · filed 2016-02-08 | -$400.00K 10-Q · filed 2016-02-08 | -$10.80M derived: sum of 3 quarters · filed 2016-09-13 | -$7.60M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-09-30 | -$6.90M 10-Q · filed 2015-11-06 | -$17.30M derived: sum of 2 quarters · filed 2016-09-13 | -$14.10M derived: sum of 3 quarters · filed 2016-09-13 | -$14.20M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-06-30 | -$10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$7.20M derived: sum of 2 quarters · filed 2016-09-13 | -$7.30M derived: sum of 3 quarters · filed 2016-09-13 | -$11.30M 10-K · filed 2016-09-13 | ||||
| 2014-03-31 | $3.20M 10-Q · filed 2015-05-08 | $3.10M derived: sum of 2 quarters · filed 2015-05-08 | -$900.00K 10-Q · filed 2015-05-08 | -$7.20M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-12-31 | -$100.00K 10-Q · filed 2015-02-06 | -$4.10M 10-Q · filed 2015-02-06 | -$10.40M derived: sum of 3 quarters · filed 2015-09-11 | -$10.20M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-09-30 | -$4.00M 10-Q · filed 2014-11-07 | -$10.30M derived: sum of 2 quarters · filed 2015-09-11 | -$10.10M derived: sum of 3 quarters · filed 2015-09-11 | -$5.50M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-06-30 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | -$6.10M derived: sum of 2 quarters · filed 2015-09-11 | -$1.50M derived: sum of 3 quarters · filed 2015-09-11 | -$8.80M 10-K · filed 2015-09-11 | -$8.60M 10-K · filed 2013-09-27 | |||
| 2013-03-31 | $200.00K 10-Q · filed 2014-05-12 | $203.00K 10-Q · filed 2013-05-10 | $4.80M derived: sum of 2 quarters · filed 2014-05-12 | -$2.50M 10-Q · filed 2014-05-12 | -$2.31M 10-Q · filed 2013-05-10 | -$8.41M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-12-31 | $4.60M 10-Q · filed 2014-02-10 | $4.82M 10-Q · filed 2013-02-11 | -$2.70M 10-Q · filed 2014-02-10 | -$2.52M 10-Q · filed 2013-02-11 | -$8.61M derived: sum of 3 quarters · filed 2014-09-30 | -$10.50M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-09-30 | -$7.30M 10-Q · filed 2013-11-12 | -$13.21M derived: sum of 2 quarters · filed 2014-09-30 | -$15.10M derived: sum of 3 quarters · filed 2014-09-30 | -$22.67M derived: sum of 4 quarters · filed 2014-09-30 | ||||
| 2012-06-30 | -$5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | -$7.80M derived: sum of 2 quarters · filed 2014-09-30 | -$15.37M derived: sum of 3 quarters · filed 2014-09-30 | -$19.70M 10-K · filed 2014-09-30 | ||||
| 2012-03-31 | -$1.89M 10-Q · filed 2013-05-10 | -$9.47M derived: sum of 2 quarters · filed 2013-05-10 | -$13.79M 10-Q · filed 2013-05-10 | |||||
| 2011-12-31 | -$7.58M 10-Q · filed 2013-02-11 | -$11.90M 10-Q · filed 2013-02-11 | ||||||
| 2011-06-30 | -$26.20M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |